http://eatg.tttp.euhttp://eatg.tttp.eu/Global-HIV-News/Prevention/Africa-No-time-to-give-up-on-HIV-fighting-gelResearchers are optimistic that they are learning as much from their failures as their successes.http://eatg.tttp.eu/Global-HIV-News/Hepatitis/Idenix-announces-removal-of-the-partial-clinical-hold-on-HCV-nucleotide-inhibitor-IDX184The Company's 12-week phase IIb study evaluating IDX184 in combination with pegylated interferon and ribavirin may continue.http://eatg.tttp.eu/Global-HIV-News/TB-Malaria/Global-malaria-deaths-twice-as-high-as-previously-estimated-IHME-study-suggestsMore than 1.2 million people died from malaria worldwide in 2010, twice the number found in the most recent comprehensive study of the disease.http://eatg.tttp.eu/Global-HIV-News/Pharma-Industry/Merck-Co-enjoys-healthy-quarter-but-expects-flat-sales-in-2012Turnover from the HIV drug Isentress (raltegravir) reached $387 million, up 24%.http://eatg.tttp.eu/Global-HIV-News/World-Policy/WHO-to-issue-guidance-on-hormonal-contraceptives-and-HIVNew findings in 2011 imply a possible increase in HIV infection among women at risk of HIV who use hormonal contraception, or increased transmission to an un-infected partner when a woman is living with HIV and using hormonal contraceptives.http://eatg.tttp.eu/Global-HIV-News/TB-Malaria/Inaccurate-TB-blood-tests-commonplace-in-many-TB-high-burden-countries17 of 22 highest TB burden countries have these assays on the market.http://eatg.tttp.eu/Global-HIV-News/Access-to-treatment/Key-generic-manufacturer-Emcure-joins-the-Medicines-Patent-PoolEmcure will be able to manufacture several products licensed to the Pool by Gilead Sciences.http://eatg.tttp.eu/Global-HIV-News/Treatment/Isentress-Intelence-Prezista-regimen-goes-the-distance-for-HIV-treatment-veteransIn treatment-experienced patients, an antiretroviral regimen containing raltegravir, etravirine and darunavir/ritonavir shows high efficacy, with a good safety profile.http://eatg.tttp.eu/Global-HIV-News/World-Policy/Media-outlets-examine-Global-Fund-s-future-as-it-enters-second-decadeDespite its staggering successes, the fund's recent troubles had threatened to overshadow its accomplishments as it prepared to mark a decade as the world's main financier of programs to fight AIDS, tuberculosis and malaria.http://eatg.tttp.eu/Global-HIV-News/Pharma-Industry/Vertex-reports-fourth-quarter-and-full-year-2011-financial-resultsSuccessful launch of INCIVEK (telaprevir) for hepatitis C and recent approval of KALYDECO (ivacaftor) for cystic fibrosis position Vertex for continued growth, earnings and cashflow.http://eatg.tttp.eu/Global-HIV-News/Pharma-Industry/Gilead-Sciences-announces-fourth-quarter-and-full-year-2011-financial-resultsFourth guarter product sales of $2.13 billion, up 11% year over year; Full year 2011 product sales of $8.10 billion, up 10% over 2010; Full year 2011 non-GAAP EPS of $3.86, up 5% over 2010; Full year 2011 operating cash flows of $3.64 billion. http://eatg.tttp.eu/Global-HIV-News/Pharma-Industry/Indian-pharma-s-outlook-stable-for-2012-says-FitchFitch Ratings says its outlook on India's pharmaceutical sector for 2012 remains stable, with earnings prospects remaining positive because of the growing global demand for generics and opportunities provided by patent expiries in developed markets.http://eatg.tttp.eu/Global-HIV-News/Prevention/For-patients-with-HIV-viral-load-is-key-in-immune-response-to-yellow-fever-vaccineIn cases where there is travel to a yellow fever-endemic country, neutralizing antibody determination should be performed prior to departure, whatever the time since a previous immunisation, especially in patients with non-controlled HIV RNA at the time of travel or immunisation.http://eatg.tttp.eu/Global-HIV-News/Prevention/Contraception-in-HIV-prevention-trials-injectable-hormonal-methods-more-effectiveWomen using injectable (hormonal) contraceptives have a significantly lower rate of pregnancy compared to those using oral contraception in a major HIV prevention study.http://eatg.tttp.eu/Global-HIV-News/MSM/Men-who-have-sex-with-men-may-now-be-the-highest-risk-group-for-HIV-in-Africa-IAVI-study-suggestsMen who have sex with men may now be at considerably higher risk of acquiring HIV than other at-risk groups such as female sex workers or young people of either sex.http://eatg.tttp.eu/Global-HIV-News/TB-Malaria/South-Africa-Africans-die-of-TB-whites-die-of-heart-diseaseTuberculosis is the number one killer of Africans in South Africa, according to the latest South Africa Survey, published by the South African Institute of Race Relations in Johannesburg last week. http://eatg.tttp.eu/Global-HIV-News/TB-Malaria/Enrollment-complete-for-REMox-TB-global-Phase-III-clinical-trialTB Alliance and partners achieve major milestone in pursuit of first new TB drug in nearly 50 years.http://eatg.tttp.eu/Global-HIV-News/MSM/Tajikistan-LGBT-community-stuck-in-the-shadowsThough Tajikistan’s criminal code does not prohibit homosexuality and homosexual relationships, LGBT individuals are still singled out for persecution by some officials. http://eatg.tttp.eu/Global-HIV-News/World-Policy/UNAIDS-Reference-Group-statement-on-the-Global-Fund-and-the-crisis-of-HIV-fundingThe Global Fund and the crisis of HIV funding — a severe setback for HIV and human rights.http://eatg.tttp.eu/Global-HIV-News/Hepatitis/Stem-cells-could-drive-hepatitis-research-forwardBy creating liver-like cells, scientists can study why people respond differently to the disease.